Literature DB >> 15027973

Mandibular reconstruction of a partial hemimandibulectomy in a dog with severe malocclusion.

Randy J Boudrieau1, Susan L Mitchell, Howard Seeherman.   

Abstract

OBJECTIVE: To report treatment of severe mandibular malocclusion (after left partial hemimandibulectomy, approximately 7 cm gap). STUDY
DESIGN: Clinical report. ANIMALS: A 14-month-old golden retriever.
METHODS: After corrective osteotomy of the right horizontal mandibular ramus, normal occlusion was reestablished and temporarily maintained while both mandibles were stabilized by miniplates on the lateral alveolar surface spanning the bilateral mandibular defects (right=1.5 cm, left=7 cm). A fenestrated, monocortical rib graft was positioned beneath the left gingival surface to protect the synthetic graft, which was secured to the miniplate. A mandibular reconstruction plate (right) and a locking mandibular reconstruction plate (left) were secured to the ventral borders of the mandibles. Recombinant bone morphogenetic protein-2 delivered in collagen tricalcium phosphate sponges (rhBMP-2 collagen-TCP sponge) was inserted into both mandibular defects.
RESULTS: New bone formation was identified at 3 months and bony remodeling was evident at recheck examinations up to 4 years. Scintigraphy (6 months, 1 year) confirmed graft revascularization and viability. Bone collected (1 year) from the left defect site had robust new bone formation and evidence of continued remodeling. Only minor complications were encountered during the postoperative period and were easily resolved.
CONCLUSIONS: Reconstruction of a large mandibular defect was facilitated by use of an osteoinductive factor (rhBMP-2 collagen-TCP sponge) as a graft substitute. CLINICAL RELEVANCE: One-step salvage and reconstruction facilitated by use of an osteoinductive factor, as a graft substitute, may be an alternative strategy for repair of large mandibular defects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15027973     DOI: 10.1111/j.1532-950X.2004.04019.x

Source DB:  PubMed          Journal:  Vet Surg        ISSN: 0161-3499            Impact factor:   1.495


  7 in total

1.  Regenerating Mandibular Bone Using rhBMP-2: Part 1-Immediate Reconstruction of Segmental Mandibulectomies.

Authors:  Boaz Arzi; Frank J M Verstraete; Daniel J Huey; Derek D Cissell; Kyriacos A Athanasiou
Journal:  Vet Surg       Date:  2014-01-10       Impact factor: 1.495

2.  Regenerating Mandibular Bone Using rhBMP--2: Part 2-Treatment of Chronic, Defect Non-Union Fractures.

Authors:  Frank J M Verstraete; Boaz Arzi; Daniel J Huey; Derek D Cissell; Kyriacos A Athanasiou
Journal:  Vet Surg       Date:  2014-01-10       Impact factor: 1.495

3.  Clinical application of recombinant human bone morphogenetic protein in cats and dogs: a review of 13 cases.

Authors:  Cory B Pinel; G Elizabeth Pluhar
Journal:  Can Vet J       Date:  2012-07       Impact factor: 1.008

4.  Effect of Escherichia coli-produced recombinant human bone morphogenetic protein 2 on the regeneration of canine segmental ulnar defects.

Authors:  Yasuji Harada; Takamasa Itoi; Shigeyuki Wakitani; Hiroyuki Irie; Michiko Sakamoto; Dongwei Zhao; Yoshinori Nezu; Takuya Yogo; Yasushi Hara; Masahiro Tagawa
Journal:  J Bone Miner Metab       Date:  2011-11-02       Impact factor: 2.626

5.  A Retrospective Study on Mandibular Reconstruction Following Excision of Canine Acanthomatous Ameloblastoma.

Authors:  Anson J Tsugawa; Boaz Arzi; Natalia Vapniarsky; Frank J M Verstraete
Journal:  Front Vet Sci       Date:  2022-05-11

6.  Analysis of the Anatomic Relationship Between the Mandibular First Molar Roots and Mandibular Canal Using Cone-Beam Computed-Tomography in 101 Dogs.

Authors:  Jamie A Berning; Christopher J Snyder; Scott Hetzel; David P Sarment
Journal:  Front Vet Sci       Date:  2020-01-17

7.  Regenerative Approach to Bilateral Rostral Mandibular Reconstruction in a Case Series of Dogs.

Authors:  Boaz Arzi; Derek D Cissell; Rachel E Pollard; Frank J M Verstraete
Journal:  Front Vet Sci       Date:  2015-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.